Cryoprecipitate
Cryoprecipitate[edit | edit source]
Introduction[edit | edit source]
Cryoprecipitate, often referred to as cryo, is a frozen blood product derived from blood plasma. It is used in medical settings primarily for its clotting properties.
Production Process[edit | edit source]
Cryoprecipitate is produced through a process of thawing fresh frozen plasma at temperatures between 1–6 °C. The plasma is then centrifuged, and the precipitate formed is collected. This precipitate is resuspended in a small volume of residual plasma, usually about 10–15 mL, and re-frozen for storage.
Composition and Uses[edit | edit source]
Cryoprecipitate contains a concentration of several clotting factors, including:
- Factor VIII (antihaemophilic factor)
- Fibrinogen
- Von Willebrand factor
- Factor XIII
- Fibronectin
It is primarily used for its clotting properties in treating conditions such as:
- Hemophilia A
- Von Willebrand disease
- Hypofibrinogenemia
- Uremic bleeding
Transfusion Practices[edit | edit source]
Cryoprecipitate is often transfused in adult patients as two 5-unit pools. This method of administration increases the concentration of clotting factors in the patient's blood.
Modern Clinical Use and Alternatives[edit | edit source]
While cryoprecipitate was once a primary choice for treating clotting factor deficiencies, its use has diminished with the availability of clotting factor concentrates. These concentrates offer more precise dosing and reduced risk of blood-borne infections. However, cryoprecipitate remains a valuable resource in certain clinical contexts where factor concentrates are not available or appropriate.
Safety and Storage[edit | edit source]
Cryoprecipitate, like other blood products, is stored in a frozen state and requires careful handling to maintain its efficacy and safety. Blood screening and donor testing are crucial to minimize the risk of transmitting infections.
Research and Development[edit | edit source]
Ongoing research in the field of hematology continues to explore the efficacy and safety of cryoprecipitate, as well as the development of more refined blood products and synthetic alternatives.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
| Cryoprecipitate Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen
